NOT-NS-26-032: Notice of Change: Early Expiration of PAR-25-326 Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Notice of Change: Early Expiration of PAR-25-326 Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Notice Number:

NOT-NS-26-032

Key Dates

Release Date:

March 12, 2026

Related Announcements

December 18, 2024 - Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed). See NOFO PAR-25-326.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform the extramural community that, effective immediately, the following NOFO is expired:

PAR-25-326: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed). No further applications will be accepted for PAR-25-326.

Applicants interested in applying to the Ultra-rare Gene-based Therapy (URGenT) program are encouraged to continue applying to the following NOFO:

PAR-25-327: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Inquiries

Please direct all inquiries to:

Division of Translational Research

National Institute of Neurological Disorders and Stroke (NINDS)

Email: [email protected]